Genemarkers, LLCGenemarkers, LLCContact: Justin Zegerius
Genemarkers is a contract research organization (CRO) that specializes in genomics.
What makes us unique? We have both an R&D Division and a CLIA-Certified Division.
The R&D Division supports preclinical biomarker discovery and validation. Genomic testing is one of the best tools in the toolbox for demonstrating biological activity and making your material stand out from the crowd. Genemarkers offers comprehensive, quality-driven genomics services that expedite the translation of basic research into pharmaceutical and consumer product development.
The CLIA Division offers pharmacogenomic testing to health care providers and genomics support for early phase clinical trials. Pharmacogenomics (PGX) testing is rapidly emerging in clinical practice as medicine moves from a one-size-fits-all model to a precision medicine approach.
Genemarkers offers genotyping and gene express-based biomarker analyses for clinical trials. Analysis of genomic biomarkers is a key component in the development of personalized medications. Our services help identify individuals for clinical trials, expediting recruitment and streamling clinical trial costs.
Our core services include gene expression, microRNA expression and genotyping analysis. The company has assembled strategic partnerships with preclinical and clinical CRO’s that perform in vivo studies to provide comprehensive services.
Genemarkers utilizes the Affymetrix microarray platform for whole genome analysis and the Taqman qPCR platform for targeted expression and genotyping analysis. In addition, the company has an on-site cell culture facility to support in vitro studies and biochemical assay development and validation.
We have an experienced management team and laboratory staff, with a breadth of scientific expertise. Our team is dedicated to providing high quality data, cost effective testing and customized personal customer services.